ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is CStone Pharmaceuticals Co. Ltd. ?
1
Weak Long Term Fundamental Strength with a 12.64% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -359.62
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 115.59%, its profits have fallen by -143.6%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is CStone Pharmaceuticals Co. Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
CStone Pharmaceuticals Co. Ltd.
115.59%
7.17
81.66%
Hang Seng Hong Kong
8.76%
0.45
19.63%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
194.13%
EBIT Growth (5y)
12.64%
EBIT to Interest (avg)
-359.62
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.89
Sales to Capital Employed (avg)
0.46
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
31.13
EV to EBIT
-26.33
EV to EBITDA
-30.28
EV to Capital Employed
185.61
EV to Sales
47.72
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-704.81%
ROE (Latest)
-112.58%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD -737.82 MM
NET PROFIT(HY)
Higher at HKD -170.9 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 4.63 times
NET SALES(Q)
At HKD 240.99 MM has Grown at 45.16%
-2What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 20.83% (YoY
NET PROFIT(Q)
Fallen at -61.79%
Here's what is working for CStone Pharmaceuticals Co. Ltd.
Operating Cash Flow
Highest at HKD -737.82 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Net Sales
At HKD 240.99 MM has Grown at 45.16%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Debtors Turnover Ratio
Highest at 4.63 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for CStone Pharmaceuticals Co. Ltd.
Net Profit
Fallen at -61.79%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (HKD MM)
Raw Material Cost
Grown by 20.83% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
